Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05268562 · ClinicalTrials.gov registry record · Phase 4

Ketamine and Kidney Injury in Cardiac Surgery

A Phase 4 study of Cardiac Surgery, sponsored by Mayo Clinic.

Active
Registry status
Phase 4
Development phase
200
Enrollment target
1
Study location

NCT05268562 is a Phase 4 study of Cardiac Surgery that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 735-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05268562, a Phase 4 study of Cardiac Surgery, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.

Conditions Studied

Interventions

  • DRUG Ketamine
  • DRUG Propofol

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-03-02
Est. Completion 2026-06
Phase Phase 4

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05268562

The ClinicalTrials.gov registry entry for NCT05268562 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 735-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (73% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT05268562 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05268562 about?

NCT05268562 is a clinical study titled "Ketamine and Kidney Injury in Cardiac Surgery". The purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.

What is the current status of trial NCT05268562?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2022-03-02. Estimated completion is 2026-06.

What conditions does trial NCT05268562 study?

This clinical trial studies the following conditions: Cardiac Surgery.

What interventions are being tested in trial NCT05268562?

The interventions under investigation include: Ketamine (DRUG), Propofol (DRUG).

Who is sponsoring clinical trial NCT05268562?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05268562 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.